Amphastar Pharmaceuticals (AMPH) Net Margin (2013 - 2026)
Amphastar Pharmaceuticals' (AMPH) quarterly Net Margin came in at 3.75% in Q1 2026, down 1108.0% year-on-year from 0.37% in Q1 2025, and down 85.57% quarter-over-quarter from 25.99% in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Net Margin (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Net Margin history runs 14 years deep, the most recent figure standing at 3.75% for Q1 2026.
- On a quarterly basis, Net Margin fell 1108.0% year-over-year to 3.75% in Q1 2026; TTM through Mar 2026 was 14.21%, a 517.0% decrease from a year earlier, with the FY2025 full-year figure at 16.84%, down 503.0% from the prior year.
- Net Margin fell to 3.75% in Q1 2026 per AMPH's latest filing, from 25.99% in the prior quarter.
- Across five years, Net Margin topped out at 27.48% in Q3 2023 and bottomed at 81.55% in Q4 2023.
- The 5-year median for Net Margin is 19.15% (2023), against an average of 12.7%.
- Across the five-year window, Net Margin plunged 10671 bps in 2023 and surged 10191 bps in 2024, its largest moves.
- Year by year, Net Margin stood at 25.16% in 2022, then slumped by 424 bps to 81.55% in 2023, then jumped by 125 bps to 20.35% in 2024, then rose by 28 bps to 25.99% in 2025, then sank by 86 bps to 3.75% in 2026.
- Per Business Quant, the three latest AMPH Net Margin figures stand at 3.75% (Q1 2026), 25.99% (Q4 2025), and 9.04% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Amphastar Pharmaceuticals | 855.23 Mn | 684.09 Mn | 70.32 Mn | 3.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.75% |
| Dec 31, 2025 | 25.99% |
| Sep 30, 2025 | 9.04% |
| Jun 30, 2025 | 17.79% |
| Mar 31, 2025 | 14.83% |
| Dec 31, 2024 | 20.35% |
| Sep 30, 2024 | 21.14% |
| Jun 30, 2024 | 20.81% |
| Mar 31, 2024 | 25.46% |
| Dec 31, 2023 | -81.55% |
| Sep 30, 2023 | 27.48% |
| Jun 30, 2023 | 18.14% |
| Mar 31, 2023 | 19.15% |
| Dec 31, 2022 | 25.16% |
| Sep 30, 2022 | 13.35% |
| Jun 30, 2022 | 14.25% |
| Mar 31, 2022 | 20.73% |
| Dec 31, 2021 | 16.52% |
| Sep 30, 2021 | 27.59% |
| Jun 30, 2021 | 8.48% |